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Reversible phosphorylation is a fundamental regula-
tory mechanism, intricately coordinated by kinases
and phosphatases, two classes of enzymes widely
disrupted in human disease. To better understand
the functions of the relatively understudied phospha-
tases, we have used complementary affinity purifica-
tion and proximity-based interaction proteomics
approaches to generate a physical interactome for
140 human proteins harboring phosphatase catalytic
domains. We identified 1,335 high-confidence inter-
actions (1,104 previously unreported), implicating
these phosphatases in the regulation of a variety of
cellular processes. Systematic phenotypic profiling
of phosphatase catalytic and regulatory subunits re-
vealed that phosphatases from every evolutionary
family impinge onmitosis. Using clues from the inter-
actome, we have uncovered unsuspected roles for
DUSP19 in mitotic exit, CDC14A in regulating micro-
tubule integrity, PTPRF in mitotic retraction fiber
integrity, and DUSP23 in centriole duplication. The
functional phosphatase interactome further provides
a rich resource for ascribing functions for this impor-
tant class of enzymes.INTRODUCTION
Reversible protein phosphorylation, catalyzed by the reciprocal
actions of kinases and phosphatases, is a ubiquitous signal
transduction mechanism, central to the regulation of many bio-
logical processes. Of these two classes of enzymes, phospha-
tases are comparatively poorly studied, despite their recognized
involvement in diseases such as Alzheimer’s, diabetes, and can-
cer (reviewed in Braithwaite et al., 2012; Gurzov et al., 2015; and
Julien et al., 2011, respectively).2488 Cell Reports 17, 2488–2501, November 22, 2016 ª 2016 The A
This is an open access article under the CC BY license (http://creativeThere are 150 genes in the human genome encoding
proteins containing domains consistent with protein dephos-
phorylation (reviewed in Duan et al., 2015). This capability
evolved independently on at least four occasions, resulting in
families with unique catalytic mechanisms and varied substrate
specificity (reviewed in Moorhead et al., 2009). Serine and thre-
onine residues are mainly dephosphorylated by phosphoprotein
phosphatase (PPP) family phosphatases, including PP1 and
PP2A, and metallo-dependent protein phosphatases (PPM,
also known as PP2C). These families diverge in sequence but
converge structurally at the catalytic center (Das et al., 1996).
Several members of the aspartate-based phosphatases (also
known as haloacid dehalogenases [HADs]) act on serine or tyro-
sine phosphorylated proteins, although other family members
preferentially dephosphorylate small molecules (reviewed in Sei-
fried et al., 2013). The majority of tyrosine dephosphorylation,
however, is mediated through the actions of the largest phos-
phatase family—the protein tyrosine phosphatases (PTPs).
This family includes the receptor and nonreceptor PTPs and
the dual-specificity phosphatases (DSPs) that can dephosphor-
ylate both tyrosine and serine/threonine residues, and in some
cases, nonprotein substrates, including phospholipids (reviewed
in Alonso and Pulido, 2016).
In this study, we employed two complementary proteomics
approaches to identify interaction partners for each human pro-
tein phosphatase, leading to an interactome of 1,335 interac-
tions (1,104 previously unreported) among 1,051 proteins.
Although this alone provides a number of promising avenues
for follow-up study, combining proteomics data with phenotypic
screens can help place these interactions within specific biolog-
ical contexts. We employed this strategy to examine mitosis—a
complex process involving widespread phosphoproteome reor-
ganization (Olsen et al., 2010). Several kinases are crucial for
mitosis and are being investigated as targets for clinical interven-
tion (Manchado et al., 2012). However, although much work has
been done on understanding the roles of a handful of phospha-
tases inmitotic regulation (reviewed inQian et al., 2013), the roles
(if any) of most other phosphatases in mitotic progression are
largely unknown. To address this, we herein complement ouruthor(s).
commons.org/licenses/by/4.0/).
(legend on next page)
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physical interaction screens by RNAi screening to identify and
study phosphatases with roles in mitotic progression, leading
us to ascribe functions to several tyrosine family phosphatases
in the regulation of mitosis.
RESULTS
Interaction Networks Reveal a Role for Phosphatases in
a Variety of Cellular Processes
Many phosphatases are regulated though protein-protein inter-
actions. For example, PPP family phosphatases such as PP1
and PP2A are regulated through combinatorial binding to a
myriad of regulatory subunits (reviewed in Shi, 2009) and
MAPK-dephosphorylating DSPs dock to their substrates
through conserved sequences (reviewed in Peti and Page,
2013). Interaction proteomics should thus be a useful starting
point for exploring the function of these enzymes. Here, we
defined a protein phosphatase as any gene encoding one of
the four types of protein phosphatase catalytic domains
(including inactive phosphatases), and compiled a list of 151
genes of interest (Table S1; overlap with the DEPhOsphorylation
Database [DEPOD] [Duan et al., 2015] is indicated). We gener-
ated a library of Gateway entry clones and 3X-FLAG-tagged
destination vectors using the longest human isoform for each
phosphatase whenever possible to maximize the number of
putative interaction partners (see the Supplemental Experi-
mental Procedures). We next generated stable isogenic
HEK293 Flp-In T-REx cell lines with tetracycline-inducible
expression, resulting in the expression of 140 protein phospha-
tases (Table S1; Figures S1A and S1B), 114 of which were pre-
viously shown to display endogenous mRNA expression in
HEK293 (Uhle´n et al., 2015; Figure 1A; Table S1). We note
that the physical interactions for the myotubularins were re-
ported elsewhere (St-Denis et al., 2015) and are only included
here for completeness. Cycling cells expressing bait proteins
were induced for 24 hr before FLAG affinity purification coupled
to mass spectrometry (AP-MS). Bait levels were monitored by
normalized spectral counts (see the Supplemental Experi-
mental Procedures; Figure 1A), and this correlated well with
the level of selected baits detected by western blot (Fig-
ure S1A). Identified interactions with prey proteins were
analyzed for significance using SAINTexpress (Teo et al.,
2014), with high-confidence interactors defined as those with
a false discovery rate (FDR) of %1% (across biological
duplicates; see Supplemental Experimental Procedures and
Figure S1C for reproducibility metrics). This revealed 797
high-confidence interactions (Figures 1B and 1C), 242 (30%)
of which were previously reported in the BioGRID database
(Chatr-Aryamontri et al., 2015; Figure 1C; Table S2).Figure 1. The Human Phosphatase Interactome
(A) Detailed interactions for 140 phosphatases identified by AP-MS and BioID.
expression levels in HEK293 are from RNA-seq (gray bars). Relative bait levels fo
spectral counts, and interactors that passed 1% FDR as assessed by SAINTexp
indicates the value ranges; see Supplemental Experimental Procedures and Tab
(B) Network of the high-confidence interactions observed for the human protein p
interactions displayed passed both the%1% FDR filter and the Specificity filter.
(C) Overview of the overlap of our interactions with those reported in the literatur
2490 Cell Reports 17, 2488–2501, November 22, 2016The PP1 and PP2A catalytic subunits, which together con-
tribute the bulk of serine/threonine phosphatase activity in the
cell (reviewed in Virshup and Shenolikar, 2009), displayed the
highest interactivity (>20 interactions each; Figure 1A). As ex-
pected, a large fraction of the PP1 and PP2A interactomes
consisted of known regulatory subunits, which are thought to
provide specificity to the dephosphorylation process (reviewed
in Shi, 2009; Figure S2). Generally, PPP family members also
generated more high-confidence interactions (mean of 18) than
the average phosphatase (mean of 6). There was no correlation
between the relative abundance of the phosphatase bait (as de-
tected by spectral counts) and the number of high-confidence in-
teractions (Figure 1A).
Recently, our laboratories have adopted a proximity-based
method, BioID (Roux et al., 2012), as a complement to AP-MS.
BioID consists of the fusion of an abortive biotin ligase (BirA*)
to a bait expressed in mammalian cells; addition of biotin cata-
lyzes its activation to biotinoyl-AMP by BirA* and allows covalent
labeling of lysines on proteins in the vicinity of the bait. Bio-
tinylated proteins are recovered by streptavidin affinity pull-
down and identified by mass spectrometry. We previously
used BioID to detect phosphorylation-dependent interactions
(Couzens et al., 2013), and for the identification of proximity
partners for components of relatively insoluble structures (Gupta
et al., 2015; Lambert et al., 2015). To survey the proximity
interaction landscape of phosphatases, and in particular of the
transmembrane receptor tyrosine phosphatases (RPTPs), we
generated 60 stable cell lines with inducible expression of
BirA*-tagged phosphatases, and performed BioID (Figure 1A;
Table S3), revealing 2,358 proximity interactions at %1% FDR,
44 of which were overlapping with the literature or our AP-MS
data (Figures 1A and 1C). For the RPTPs, a dramatic gain in
proximity interactions was observed (57 interactions by
AP-MS, an average of 3 per RPTP; 1,083 interactions by BioID,
an average of 60 per RPTP; all at an FDR % 1%; Figure 1A). It
was, however, difficult to identify high-confidence preys that
exhibited a preference for one or a subset of phosphatases
(i.e., that may mediate their specific biology) rather than
merely indicating plasma membrane localization. We therefore
implemented a secondary Specificity score that evaluates
the quantitative enrichment of preys with specific baits against
the same prey across all other baits profiled (see the Supple-
mental Experimental Procedures and Table S3 for the bench-
marking against literature interactions). Following application of
the Specificity cut-off, we report 561 high-confidence specific
BioID interactions across the 60 baits profiled, 33 of which
overlapped with the literature (Figures 1B and 1C; Table S3).
We note several broad features for the phosphatase interac-
tome. Connections to kinaseswere exemplified by the numerousPhosphatases are organized by family and sequence similarity. Endogenous
r AP-MS (pale green) and BioID (pale orange) were determined by normalized
ress are shown for AP-MS (dark green) and BioID (dark orange). The legend
les S1–S3 for details.
hosphatases. For AP-MS, interactions%1% FDR are displayed. For BioID, the
e (BioGRID). See also Figure S1.
Figure 2. Selected Examples of Phosphatase Interactions
(A) MAPK-interacting phosphatases.
(B) 14-3-3 protein-interacting phosphatases.
(C) PP2A-interacting phosphatases. For (A), (B), and (C), the data are represented as Cytoscape networks with each phosphatase family colored differently; see
inset in (A) for other details.
(D) Interactome for the tensin family highlighting interactions with the dystrophin complex (SNTB2, UTRN, DTNB, DMD, SNTB1); previously reported interactions
are highlighted in green.
(E) DUSP9 interacts with primase (PRIM1, PRIM2) and with the Elongator complex (ELP2, ELP3, IKBKAP).
(F) STYX interacts with SKP1 and several F-box proteins, whereas STYXL1 recovers cytoskeletal components.
(G) BioID reveals specific proximity interactions with exocytosis/trafficking components for PTPRH and PTPRJ; bold italics indicate that the reported
interaction(s) satisfied both our FDR and specificity filter cutoffs. For (D)–(G), the data are represented as dot plots; see inset in (E) for details. See also
Figures S2 and S3.phosphatases that associated with MAP kinases, as expected
(Figure 2A). Phosphatases from several families also interacted
with at least one of the phosphothreonine binding 14-3-3 pro-
teins (Figure 2B), including several phosphatases with experi-mentally determined (CDC25B, CDC25C, PTPN3, and SSH1)
or computationally predicted (PPM1H, TENC1) 14-3-3 binding
sites. We also detected several connections between phospha-
tases, notably for PP2A holoenzymes, which were recovered asCell Reports 17, 2488–2501, November 22, 2016 2491
Figure 3. Protein Phosphatases from All Evolutionary Families Play Roles in Mitosis
(A) Schematic workflow of RNAi screening and validation process highlighting the number of hits.
(B) Human protein phosphatases mitotic hits, by evolutionary family. Phylogenetic trees represent alignments of the longest isoforms of the full-length proteins.
Phosphatases are labeled by official gene symbols. Colored circles, the size of which corresponds to the cumulative Z score from the mitotic index and high-
resolution analyses, indicate primary and validated hits.
(C) PPP family phosphatase subunit hits in the RNAi screen. See also Figure S4.preys with several unrelated phosphatases (Figure 2C). Interac-
tions point to putative roles for several phosphatases, e.g., ten-
sins with the dystrophin, syntrophin, and synaptobrevin complex
(Figure 2D); DUSP9 with DNA primase and components of the
RNAPolymerase II-associated elongator acetyltransferase com-
plex (Figure 2E); and STYXwith SKP1 and several F-box proteins
(Figure 2F; see additional examples in Figure S2).
The BioID dataset also permitted the confirmation of previ-
ously known interactions to specific phosphatases (e.g., GRB2
with PTPRA [den Hertog et al., 1994]; TRIO and the liprin PPFIA1
with PTPRF, PTPRS, and PTPRD [Debant et al., 1996; Pulido
et al., 1995; Figure S3]) and expanded the number of functional
hypotheses for less characterized phosphatases, including
PTPRH and PTPRJ in exocytosis (Figure 2G) and PTPRU in actin
regulation (Figure S3). Intriguingly, PTPRT was the only phos-2492 Cell Reports 17, 2488–2501, November 22, 2016phatase to significantly interact with phosphorylase kinase, sug-
gesting a link to glycogen metabolism (Figure S3). To facilitate
exploration, the entire dataset may be accessed via prohits-
web.lunenfeld.ca. Taken together, AP-MS and BioID dramati-
cally expand the catalog of physical interactions established
by protein phosphatases.
Mitosis Requires Phosphatases from All Evolutionary
Lineages
To identify phosphatases with potential roles in mitosis, we per-
formed a high-resolution endoribonuclease-generated small
interfering RNA (esiRNA) screen (Kittler et al., 2007; Figure 3A).
Briefly, HeLa cells were transfected with esiRNAs targeting 228
genes encoding 151 phosphatases and 77 known phosphatase
regulatory subunits (Table S4). Note that we did not verify the
Table 1. Validated Phosphatases and Regulatory Subunits with Potential Roles in Mitosis
Gene Name Aliases Family
Mitotic
Index
Z Score
Abnormal
Spindle
Z Score
Validation
New
esiRNA
Validation
siRNA
RNAi-
Resistant
Test
Previous
Hit In
Screen
Other
Literature
Evidence
PPP2R1A PP2A-Aa, PR65A associated subunit (PPP) + + + + + +
SBF2 MTMR13, DENND7B PTP family (myotubularin) + + + + +
PPP1R14A CPI-17 associated subunit (PPP) + + +
TPTE PTEN2, CT44 PTP family (PTEN/tensin) + + – +
PPP2CA PP2Ac, PP2Aa PPP family + + + + + +
PPP1R14D CPI17-like, GBP1 associated subunit (PPP) + – – +
PPM1B PP2Cb PPM family + + + –
PPP1R9A NRB1, Neurabin-1 associated subunit (PPP) + + + –
PPM1A PP2Ca PPM family + + + –
PPP3R2 Calcineurin subunit B associated subunit (PPP) + – – +
PPP1R12A MYPT1 associated subunit (PPP) + + – + + +
PPP1R7 SDS22 associated subunit (PPP) + – + + +
PPP1R14C CPI17-like, KEPI associated subunit (PPP) + + + –
PHACTR3 Scapinin, PPP1R123 associated subunit (PPP) + + + – +
PPM1K PP2Cm, PP2Ck PPM family + + + –
DUSP19 SKRP1, LMW-DUSP3 dual specificity PTP family + + + + + +
PPP2R5D PP2A B’d, PP2A B56d associated subunit (PPP) + + + + +
TPTE2 TPIP PTP family (PTEN/tensin) + + + +
DUSP23 VHZ, LDP-3 dual specificity PTP family + + + + +
CDC14A hCDC14 dual specificity PTP family – + – + + +
PPP2R5E PP2A B’ε, PP2A B56ε associated subunit (PPP) – + – + +
PTPRF LAR classical receptor PTP – + – + + +
PPP1CA PP1A, PP1a PPP family – + + + + +
PPP1R16B TIMAP, ANKRD4 associated subunit (PPP) – + +
PPP1R1C IPP5 associated subunit (PPP) – + – +
CTDSPL RBSP3, HYA22, SCP3 aspartate-based HAD
family
– + + + +
PPP2CB PP2CB, PP2Ab PPP family – + + – +
RNGTT HCE, CAP1A dual specificity PTP family – + + –
TNS3 TENS1 PTP family (PTEN/tensin) – + +
EPM2A Laforin dual specificity PTP family – + – +
PTPN23 HD-PTP classical nonreceptor PTP – + +
PTPRE PTPε, RPTPepsilon classical receptor PTP – + – +
PTPRT PTPr, RPTPrho classical receptor PTP – + – + +
Hits are sorted by decreasing Mitotic Index Z score, then by decreasing Abnormal Spindle Z score in the primary screen. Hits that passed selected
cutoffs in the primary and validation screens are indicated by ‘‘+,’’ whereas ‘‘–’’ indicates that they did not pass. Empty is not tested. Evidence of a
mitotic role from similar mitotic screens or other literature sources is also indicated. See Table S4 for complete details.expression of these genes; however, 113 of the 140 phospha-
tase catalytic subunits we profiled as baits in our interactome
are reported to be endogenously expressed in HeLa cells, a
88% overlap with HEK293s (Table S1; Uhle´n et al., 2015). Mitotic
indices were calculated using DAPI and phospho-Histone H3
labels (Figure S4A). Additionally, high-resolution images were
manually annotated for the presence of abnormal metaphase
structures, such as misaligned chromosomes, mono/multipolar
spindles, centrosomal defects, etc. (Figure S4B; Table S4). In
total, the primary screen identified 48 candidate mitotic regula-
tors (mean Z score of R2 for mitotic index and/or R2.5 forabnormal mitosis). Of these, 27 affected mitotic progression,
45 affected spindle assembly, and 24 affected both processes
(Figure S4C).
We validated 33 (69%) of these hits using at least one
orthogonal silencing trigger, either siRNAs and/or nonoverlap-
ping esiRNAs (Figures 3B and S4D). The validation data are
summarized in Table 1 (details in Table S4) along with any
previously reported mitotic function for any of our validated
targets. For example, the PPP family was represented by
PP1 and PP2A, both of which have multiple roles in mitosis
(De Wulf et al., 2009). Depletion of either catalytic PP1Cell Reports 17, 2488–2501, November 22, 2016 2493
(PPP1CA) or PP2A (PPP2CA/B) subunits or several known
scaffolding, regulatory, or inhibitory proteins led to defects
in mitosis (Figure 3C). Several of these hits have been
well documented, e.g., PPP1R7 (SDS22) targets PP1 to the
kinetochores where it antagonizes Aurora B activity (Posch
et al., 2010), whereas PPP1R12 (myosin phosphatase target
subunit; MYPT1) enables PP1 to counter PLK1 activity at
centromeres (Matsumura et al., 2011). PP1 regulatory subunits
not previously associated with mitosis included PPP1R9A,
PHACTR3, and several members of the PPP1R14 family of
PP1 inhibitory proteins (PPP1R14A/C/D; note that PPP1R14A
preferentially inhibits MYPT1-PP1 [Eto et al., 2004] consistent
with a mitotic function). Non-PPP serine/threonine phosphatase
hits included the PPM phosphatase PPM1A and the HAD-like
phosphatase CTDSPL. Strikingly, 13 of the validated mitotic
regulators were members of the protein tyrosine phosphatase
family, suggesting that phosphatases from all evolutionary
families are involved in the regulation of mitotic cell division
(Figure 3B).
PTP Family Phosphatases Are Implicated in Mitotic
Processes
To confirm the surprising identification of many PTPs family
members in our screen, we selected six of them for further inves-
tigation: CDC14A, DUSP19, DUSP23, PTPRF, PTPRT, and
SBF2. To confirm the specificity of the phenotypes, HeLa Flp-
In T-REx cells harboring siRNA-resistant inducible variants of
each of these PTPs were generated. In each case, siRNA-medi-
ated depletion resulted in increased mitotic defects, which were
prevented with concurrent expression of the RNAi-resistant PTP
(Figure 4A).
The phenotypes observed upon depletion of many of the
phosphatases were similar: abnormal spindle morphology, with
notable numerical and structural centrosomal abnormalities
coincident with mitotic arrest. However, when the results from
the phenotypic screens were considered in the context of the
interaction data (Figure 4B), more precise roles for four of these
PTP phosphatase hits began to emerge.
For example, DUSP19 (also known as SKRP1 or LMWDSP3) is
an atypical DSP previously implicated in JNK signaling (Zama
et al., 2002). Unlike several other DSPs in our dataset (Fig-
ure 2A), DUSP19 did not interact with JNK isoforms, consistent
with the fact that it lacks the MAP kinase docking motif (Patter-
son et al., 2009). Instead, DUSP19 interacted with catalytic
(PPP2CA), scaffolding (PPP2R1A), and regulatory (PPP2R5D
and PPP2R5E) subunits of PP2A, all of which were also validated
hits in our screen (Figure 3C). PPP2R5D and PPP2R5E have
recently been shown to recruit PP2A to the anaphase central
spindle (Bastos et al., 2014), which controls the assembly of
the actin-rich cleavage furrow (Fededa andGerlich, 2012). As ac-
tins were also prominent DUSP19 interactors, we hypothesized
that DUSP19 may play a role in anaphase. Live-cell imaging of
HeLa cells stably expressing RFP-Histone 2B and GFP-Tubulin
revealed no significant difference in the duration of early mitotic
events (from nuclear envelope breakdown [NEB] to anaphase
onset) in DUSP19 siRNA-treated cells (Figure 4D; Movies S1
and S2), but these cells progressed through late mitosis more
rapidly than control cells (Figure 4E;Movies S1 and S2), suggest-2494 Cell Reports 17, 2488–2501, November 22, 2016ing that DUSP19may inhibit the progression of latemitosis. Cells
depleted of DUSP19 also displayed defects in late mitosis, re-
sulting in cell death or multinucleated daughter cells (Figure 4F;
Movie S2). The nonspecific mitotic spindle defects and modest
increase in mitotic index (Table S4) detected in the initial screen
are likely due to continued division of these multinucleated
daughter cells.
Depletion of CDC14A, a DSP with sequence homology to the
yeast mitotic phosphatase Cdc14p (Li et al., 1997), resulted
in abnormal spindles and defects in chromosome alignment
at the metaphase plate (Figure 4G; Table S4), suggesting that
it affects mitotic spindle microtubule organization. CDC14A
AP-MS revealed interactions with components of the recently
discovered 3M complex, which acts in microtubule stabilization
(Figure 4H; Li et al., 2014; Yan et al., 2014). Similarly to
CDC14A, depletion of 3M complex components resulted in
altered microtubule dynamics, chromosome congression fail-
ure, and mitotic arrest (Yan et al., 2014) and like the 3M com-
plex, CDC14A localized to the centrosome (Figure S5), and
affected cell shape throughout the cell cycle (Figure 4I).
Although phosphoregulation of the 3M complex has yet to be
investigated, it is noteworthy that all 3M components
interacting with CDC14A contain identified proline-directed
phosphoserine residues (Dephoure et al., 2008; Kim et al.,
2012), suggesting that a proline-directed CDC14 phospha-
tase (Gray et al., 2003) might regulate the complex through
dephosphorylation.
The Receptor Tyrosine Phosphatase PTPRF Is a Crucial
Component of Mitotic Retraction Fibers
PTPRF (also known as LAR [leukocyte antigen-related]) is a
transmembrane RPTP whose depletion led to multipolar spin-
dles and/or chromosome misalignment (Figure 5A). PTPRF,
which is important for the development of the nervous system
(Chagnon et al., 2004), contains several cell adhesion molecule
(CAM)-like domains in its extracellular portion (O’Grady et al.,
1994) and regulates focal adhesions (Sarhan et al., 2016;
Serra-Page`s et al., 1995; Streuli et al., 1990). We observed that
GFP-PTPRF localized to the plasma membrane as expected
(Figure S6A), but strikingly also to long extracellular fibers during
mitosis (Figure 4B) where it exhibited a punctate pattern, resem-
bling beads on a string (Figure 4B, zoomed panels). These fibers
were similar to retraction fibers, actin-rich mitotic remnants of
interphase focal adhesions that maintain attachment between
mitotic cells and the extracellular matrix, and control mitotic
spindle positioning in response to extracellular cues (Fink
et al., 2011; The´ry et al., 2007). Themitotic phenotypes observed
upon PTPRF depletion resembled loss of the retraction fiber
component mitotic spindle positioning (MISP) (Maier et al.,
2013; Zhu et al., 2013). Consistent with a specific role in retrac-
tion fiber formation, depletion of PTPRF resulted in the loss of
retraction fibers from metaphase cells (Figure 5C) but caused
no obvious changes in interphase actin cytoskeleton orga-
nization (Figure S6B), suggesting that the effect is specific to
retraction fibers. Loss of retraction fibers was prevented by
siRNA-resistant PTPRF-GFP expression (Figure 4D). Little is
known about the composition of retraction fibers, although
actin-associated focal adhesion proteins seem important (Maier
Figure 4. PTP Family Phosphatases Play
Roles in Mitosis
(A) HeLa Flp-In T-REx cells with stable expression
of indicated siRNA-resistant GFP-PTPs were
treated with their respective PTP RNAi, with or
without tetracycline to induce PTP expression.
Cells were analyzed for mitotic defects. Data
represent the mean of three independent ex-
periments ± SE. ns, not significant; **p < 0.01;
***p < 0.0001.
(B) Strategies to combine physical and functional
screens to annotate mitotic hits: phosphatase hits
that have interactors with known mitotic function
are prioritized for functional analysis.
(C) DUSP19 interactions with actin and PP2A. See
legend inset for details.
(D and E) HeLa cells with stable expression of GFP-
Tubulin and RFP-Histone 2B were treated with
control or DUSP19 siRNA and subjected to live-cell
imaging. For individual cells, the time from nuclear
envelope breakdown (NEB) to anaphase (D) and
from anaphase to completion of abscission (E) was
measured. Results show one of three replicate
experiments. ns, not significant; **p < 0.01.
(F) Representative still images from cells in (D) and
(E). Numbers in bottom left indicate minutes
elapsed between adjacent panels. Scale bars,
20 mm. In DUSP19 images, timing relates to cell 1.
(G) Sample images of mitotic HeLa cells, treated
with control or CDC14A siRNA. Scale bars, 10 mm.
(H) CDC14A interactions with 3M complex com-
ponents. See legend inset in (C) for details.
(I) Sample images of interphase HeLa cells, treated
with control or CDC14A siRNA. Scale bar, 10 mm.
See also Figure S5 and Movies S1 and S2.et al., 2013; Zhu et al., 2013). PTPRF BioID preys were signifi-
cantly enriched for proteins associated with cell-cell junctions
(Gene Ontology [GO]: 0005911; p = 2.04E12), focal adhesions
(GO: 0005925; p = 7.07E08), and the actin cytoskeleton (GO:
0015629; p = 3.38E04; Figure 4E). These interactors could
have important roles on retraction fibers, therefore regulating
mitotic spindle organization.Cell ReportDUSP23 Interacts with PLK4 and
Regulates Centriole Duplication
The atypical DSP DUSP23 (also known as
VHZ; Alonso et al., 2004;Wu et al., 2004) is
a 16-kDa protein comprising essentially
only aPTPdomain.AP-MS identifiedasin-
gle high-confidence prey: the serine/thre-
onine kinase PLK4, a master regulator of
centriole duplication (Habedanck et al.,
2005; Figure 6A). DUSP23 depletion re-
sulted in a marked increase in abnormal
mitoses (Figure 6B), with increased
monopolar and multipolar spindles (Fig-
ures 6C and 6D), and fewer than four cen-
trioles (Figures 6D and 6E). In a sensitized
centriole duplication assay (Kleylein-
Sohn et al., 2007), DUSP23 RNAi inhibited
Myc-PLK4-induced centriole overduplica-tion in S-phase-arrested U-2 OS cells to levels comparable to
the depletion of two core centriolar components, CEP120 and
CEP135 (Comartin et al., 2013; Kleylein-Sohn et al., 2007; Mah-
joub et al., 2010) (Figure 6F). Like PLK4, DUSP23 RNAi resulted
in an accumulation of S- and G2/M-phase cells (Figure S7A).
The decrease in centrioles observed upon DUSP23 deple-
tion was partially prevented by expression of siRNA-resistants 17, 2488–2501, November 22, 2016 2495
Figure 5. PTPRF Is a Crucial Component of Extracellular Mitotic Retraction Fibers
(A) Sample images of mitotic HeLa cells, treated with siRNA, and stained to visualize the mitotic machinery. Scale bars, 10 mm.
(B) HeLa Flp-In T-REx cells with stable, inducible expression of PTPRF-GFP were treated with control or PTPRF siRNA. Zoomed images represent the boxed
region in merged images. Scale bars, 10 mm.
(C) HeLa cells treated as in (A) were stained for phalloidin and endogenous PTPRF. Scale bars, 10 mm.
(D) HeLa Flp-In T-REx cells with induced expression of siRNA-resistant PTPRF-GFP were treated with siRNA and analyzed for the presence of retraction fibers.
Data represent the mean of three independent experiments ± SE. *p < 0.05, **p < 0.01.
(E) PTPRF BioID preys with an FDR of%1% and a project frequency of%50%. Preys were sorted into GO terms using the Panther Overrepresentation Test. See
also Figure S6.GFP-DUSP23, demonstrating the specificity of the phenotype
(Figure 6G). Expression of a DUSP23 phosphatase-dead mutant
(C95S), however, did not prevent centriole loss. Intriguingly,
DUSP23 also possesses phosphotransferase ability in vitro—
i.e., instead of releasing inorganic phosphate after dephosphor-
ylation, DUSP23 can transfer phosphate to another phosphory-
latable substrate (Kuznetsov and Hengge, 2013). A DUSP23
point mutant with normal phosphatase activity, but deficient in
in vitro phosphotransferase activity (P68V; Kuznetsov and
Hengge, 2013) also failed to prevent centriole loss, suggesting
that dephosphorylation and transphosphorylation by DUSP232496 Cell Reports 17, 2488–2501, November 22, 2016are both important for centriole duplication. Taken together,
the data suggest that loss of DUSP23 activity leads to decreased
centriole duplication, which results in spindle polarity defects
upon progression into mitosis.
DUSP23 interacts with PLK4, suggesting that DUSP23 acts
early in the centriole duplication pathway. Using three-dimen-
sional structured illumination microscopy (3D-SIM), we exam-
ined early and late markers of centriole duplication in S-phase
Myc-PLK4-overexpressing cells (Comartin et al., 2013). Deple-
tion of DUSP23 resulted in centrioles lacking the late daughter
marker Centrin (CETN), and devoid of the typical ‘‘florette’’
Figure 6. DUSP23 Regulates Centriole Duplication through PLK4
(A) PLK4 is the only DUSP23 interactor identified by AP-MS with a FDR of%1%.
(B) HeLa cells were treated with siRNA and analyzed for mitotic spindle defects. Data in (B), (C), (E), (F), and (G) represent the mean of three independent ex-
periments ± SE. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.0001.
(legend continued on next page)
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arrangement of overduplicated centrioles (Kleylein-Sohn et al.,
2007). Importantly, DUSP23 inhibited the recruitment of
CEP135 to the procentriole daughter assembly region, which is
an early step that involves CEP135 forming a ring coincident
with the PLK4-labeled mother ring structure (Comartin et al.,
2013; Figure 6H). These phenotypes were similar to centrioles
depleted of STIL, a key target of PLK4 kinase activity and an early
regulator of centriole biogenesis (Arquint et al., 2015; Moyer
et al., 2015; Figure 6H). Interestingly, DUSP23 depletion did
not affect the recruitment of STIL to the mother centriole in
Myc-PLK4 cells (Figure 6I), a very early event in the initiation of
centriole duplication (Comartin et al., 2013; Moyer et al., 2015).
However, the normal progression of STIL localization from just
peripheral to the mother (early) to the base of the daughter
centriole (late) during centriole daughter assembly and elonga-
tion was arrested (Figure 6I).
Regulation of PLK4 levels is achieved via phosphoregulation
(Cunha-Ferreira et al., 2009; Rogers et al., 2009). DUSP23 deple-
tion resulted in increased HA-PLK4 in cells (Figure S7B). HA-
PLK4 intensity at the centriole was also increased upon
DUSP23 depletion (Figures S7C and S7E). We also monitored
PLK4 phospho-S305 intensity (as a surrogate for PLK4 kinase
activity; Mason et al., 2014) in cells expressing HA-PLK4
and depleted of DUSP23. The amount of associated PLK4
phospho-S305 label did not increase proportionately, resulting
in a significantly lower ratio of phospho-S305 staining to total
PLK4 staining at the centriole (Figures S7D and S7E). This sug-
gests that loss of DUSP23 results in decreased centriolar PLK4
activity. Contrary to previous work (Tang et al., 2010), in our
hands, DUSP23 did not localize to centrioles (Figure S7F).
DUSP23 did not detectably interact with any centriolar proteins
other than PLK4 (Table S2), suggesting an early function for
DUSP23 in the centriole duplication cycle, potentially through
the modulation of PLK4 activity.
DISCUSSION
We have used a combined physical and functional screening
approach to uncover cellular roles for protein phosphatases,
with a focus on the critical process of mitosis. Our high-resolu-
tion RNAi screen identified phosphatases from every evolu-
tionary family, and every subgroup of the PTP family, as mitotic
regulators. Individual PTPs play distinct roles in mitotic progres-
sion, including centriole duplication (DUSP23), microtubule spin-
dle stability (CDC14A), cell-matrix attachment (PTPRF), and
mitotic exit (DUSP19).
Our proteomic screening also identified previously unreported
interactions for a variety of phosphatases, and these interactions(C) HeLa cells were treated as in (B). Metaphase cells were analyzed for polarity
(D) Sample cells from (C). Scale bars, 10 mm.
(E) HeLa cells were treated as in (B). Metaphase cells were analyzed for the num
(F) U2 O-S cells with stable, inducible expression of Myc-PLK4 were treated with t
and Myc-PLK4 induction for 24 hr. Cells were analyzed for centriole overduplica
(G) HeLa Flp-In T-REx cells were treated with siRNA with concurrent induction of
centriole number. Lysates were also generated and subjected to western blot an
(H and I) Myc-PLK4 U-2 OS cells were transfected with siRNA for 64 hr with Myc
overnight treatments with aphidicolin and RO3306. Cells were imaged by 3D-SIM
2498 Cell Reports 17, 2488–2501, November 22, 2016can provide clues regarding their functions (in mitosis or other
cellular processes). Our results suggest that, in contrast to
PPP family members and the MAP kinase phosphatases, the
majority of phosphatases do not establish multiple stable pro-
tein-protein interactions, a phenomenon that appears to be
evolutionarily conserved (Breitkreutz et al., 2010). Yet, several
of our human phosphatases interacted with components of the
phosphorylation machinery—kinases, phosphobinding proteins,
and other phosphatases (Figure 2). This is consistent with the in-
terconnectivity detected for yeast kinases and phosphatases
(Breitkreutz et al., 2010), and later for human CMGC family ki-
nases (Varjosalo et al., 2013). Our findings therefore accentuate
the complexity of phosphorylation-based signal transduction,
whereby modifying enzymes can act in phosphoregulatory cas-
cades, and cross talk to other enzymes may add robustness to
signaling systems (Levy et al., 2010).
Our findings extend other excellent existing resources for
generic interactions (BioGRID [Chatr-Aryamontri et al., 2015],
IntAct [Orchard et al., 2014], etc.) by systematically assessing
nearly all human phosphatase catalytic subunits under the
same conditions by AP-MS, permitting comparative assess-
ments (through semiquantitative measurements and statistical
evaluation of each interaction). We note that, although we have
identified many stable interactions, our study was not designed
to identify substrates for phosphatases: phosphatases establish
short-lived interactions with their substrates, which are typically
difficult to capture by biochemical enrichment (AP-MS). It is
also not clear that the dynamics of interactions for kinases and
phosphatases are compatible with BioID (this study and other
unpublished data from the A.-C.G. laboratory), in contrast to in-
teractions involving direct phospho-binding modules (Couzens
et al., 2013) or ubiquitin ligase substrates (Coyaud et al., 2015).
As such, it is not surprising that the overlap with phosphatase-
substrate interactions reported in DEPOD (Duan et al., 2015),
to our knowledge the most comprehensive database of such re-
lationships, is very low, with 21/838 annotated relationships de-
tected here. Clearly, more work will be needed—likely including
global phosphoproteomics approaches (reviewed in Gingras
and Wong, 2016)—to fully understand the signaling events
downstream of each phosphatase.
Globally, our work identifies a variety of phosphatase protein-
protein interactions and underscores how much there is to be
learned about these enzymes. Although we have performed
initial follow-up experiments on selected phosphatases in
mitosis, other hits in our phenotypic screenwarrant further inves-
tigation as will deciphering the role of the hundreds of additional
interactors, in other cellular process. To assist the community in
the continued exploration of our data-rich resource, we havedefects.
ber of centrioles.
he indicated siRNAs for 48 hr before concurrent S-phase arrest with aphidicolin
tion.
siRNA-resistant versions of GFP-DUSP23. Metaphase cells were analyzed for
alysis.
-PLK4 induction starting after 24 hr. Cells were arrested in G2 with sequential
. Scale bars, 500 nm. See also Figure S7.
deposited the mass spectrometry data to the public repository
MassIVE (http://massive.ucsd.edu/ProteoSAFe/static/massive.
jsp) and also present our dataset in its entirety on a dedicated
website (prohits-web.lunenfeld.ca).
EXPERIMENTAL PROCEDURES
Physical Interactome Mapping
Generation of FLAG- and BirA*-tagged phosphatase cell lines and mass spec-
trometric analysis was performed essentially as described (Couzens et al.,
2013), and significant interactions were scored using SAINTexpress (Teo
et al., 2014).
Phenotypic Screening
esiRNAs were designed and generated as in Kittler et al. (2005). HeLa cells
were screened for mitotic phenotypes essentially as in Lawo et al. (2009).
Cell Biology and Biochemistry
Cell culture, transfection, immunofluorescence, fixed and live-cell imaging,
and western blot analysis were performed as previously described (St-Denis
et al., 2015). Centriole duplication assays and 3D-SIM were performed as
described in Comartin et al. (2013). All reagents generated and materials
used are summarized in Table S1.
Accessing the Data
The accession numbers for mass spectrometry data reported in this paper are
MassIVE: MSV000079889, MSV000079891, and MSV000079890. The mass
spectrometry data are also associated with ProteomeXchange: PXD004525,
PXD004527, and PXD004526. Data are also available in a searchable format
at prohits-web.lunenfeld.ca.
See also the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, four tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2016.10.078.
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